Million Insights
Market Research Released A New Research Report On Global Gastroesophageal
Reflux Disease (GERD) Therapeutics Market - Forecast Up To 2025. Report Provide
Overview Of Top Key Players, Share Analysis, Size, Stake, Progress, Trends And
Their Strategic Profiling In The Market, Comprehensively Analyzing Their Core
Competencies, And Drawing A Competitive Landscape For The Market.
Pune, India - Gastroesophageal Reflux Disease (GERD)
Therapeutics Market size was valued at USD 5.66 billion in 2016 and by
is estimated to be USD 4.34 billion by 2025, it is anticipated to observe a
decrease in its revenue at a negative CAGR of -2.9%. Expiration of patented
blockbuster drugs, which are indicated for the management of disorders of acid
reflux is major restraining factors for this market.
With strong clinical pipelines and patent litigations, the
market continues to experience significant changes. Proton pump inhibitors
(PPI) and antagonists of histamine H2 receptor have the importance in current
scenario of the market.
To Get Sample Report
visit @ https://www.millioninsights.com/industry-reports/gastroesophageal-reflux-disease-gerd-therapeutics-market/request-sample
Upon loss of patent protection of formerly leading branded
drugs, generic molecules with low-price can ingest the sales of the branded
ones up to 90%. Rising number of companies being exposed to price scrutiny
associated with shift in the focus of government on the promotion of consumer
convenience will stimulate further reduction of drug prices. Although market
turnover is affected by the expiration of major patents and the demand of drugs
used to reduce acid, due to the increasing prevalence of heartburn, is
anticipated to increase in the upcoming years.
The devices of GERD serves as a substitute for management of
heartburn, because of low rate of success and failure in clinical trials.
Hence, very limited acceptance of devices of GERD management contribute for the
rising demand of drugs having acid neutralizing property, as the major therapy
approach.
Nevertheless, the advent of devices which are minimally
invasive to address anatomical defects are gaining popularity coupled with
supportive evidence from clinical data for performing various procedures
including trans oral fundoplication, which helps in preventing reflux of
non-acid and acid contents. The adoption of these devices have been further
reinforced in the U.S. in 2016 with the advent of a CPT code (43210) which
helps in facilitating reimbursement process.
Drug Type Insights
In 2016, market was dominated by the antacids segment and is
anticipated to keep its top position over the forecast period. Most preferred
first-line therapy for infrequent and mild symptoms is antacids, as the therapy
neutralize the secretion of gastric acid immediately. Convenient OTC
(over-the-counter) accessibility various forms such as syrups, powders and
tablets is accountable for the extreme adoption. Moreover, the AHFS (American
Hospital Formulary services), amongst other countries, enlisted over 120
preparations too advocate.
In 2016, the second largest segment was found to be PPIs as
it is the most common medication prescription type for the diseases such as
heartburn. Generics inflow leading to the loss of exclusiveness of popular
drugs, including Prilosec and Nexium, is estimated to negatively affect the
sales of branded versions. A further decrease is appearing more with the
expected expiration of other patented drugs, such as Dexilant.
To Browse Complete
Report visit @ https://www.millioninsights.com/industry-reports/gastroesophageal-reflux-disease-gerd-therapeutics-market
Market Segment:
GERD Therapeutics Drug Type Outlook (Revenue, USD Million, 2014 - 2025)
•
Antacids
• H2 Receptor Blockers
• Proton Pump Inhibitors (PPIs)
• Pro-kinetic agents
GERD Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Middle East and Africa (MEA)
• South Africa
Get in touch
At Million Insights, we work
with the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist,
USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor,
Manikchand Galleria,
Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
tel: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com
No comments:
Post a Comment